GCIA
ACLX

Gabelli & Co Investment Advisers’s Arcellx ACLX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.5M Buy
+152,400
New +$13.5M 2.6% 8

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Gabelli & Co Investment Advisers's ACLX Position: Q1 2026 in Review

Gabelli & Co Investment Advisers opened a new position in Arcellx (ACLX) in Q1 2026: 152,400 shares worth $17.5M. The stake represents 2.6% of the portfolio and ranks #8 among its holdings.

239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Gabelli & Co Investment Advisers held 152,400 shares of Arcellx worth $17.5M as of Q1 2026.
  • Arcellx was a new Gabelli & Co Investment Advisers position in Q1 2026.
  • Arcellx made up 2.6% of Gabelli & Co Investment Advisers's portfolio in Q1 2026, its #8 holding.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.